The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors - PubMed (original) (raw)
The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors
K D Karpa et al. Mol Pharmacol. 2000 Oct.
Abstract
We have generated a stable cell line expressing FLAG epitope-tagged D3 dopamine receptors and used this cell line to study D3 receptor-protein interactions. To analyze protein interactions, we separately introduced into the stable cell line either D3 receptors carrying an hemagglutinin (HA) epitope tag, or an HA-tagged version of the D3 receptor splice variant D3nf. A combination of confocal laser microscopy and coimmunoprecipitation was used to assay the formation and expression pattern of D3-D3 homodimers or D3-D3nf heterodimers. When coexpressed in HEK 293 cells, FLAG- and HA-tagged D3 receptors exhibited a similar plasma membrane distribution. Using an HA epitope tag-specific antibody, we coimmunoprecipitated HA- and FLAG-tagged D3 receptors, suggesting that D3 receptors are capable of forming homodimers. Epitope-tagged D3nf polypeptides exhibited a markedly different cellular distribution than D3 receptors. When expressed in HEK 293 cells, either alone or in combination with FLAG-tagged D3 receptors, D3nf exhibited a punctate perinuclear distribution. When D3nf was introduced into the stable D3-expressing cell line, D3 receptors were no longer visualized at the plasma membrane. Instead, D3 and D3nf showed a similar, predominantly cytosolic, localization. Using the HA-specific antibody, we were able to coimmunoprecipitate D3 and D3nf polypeptides from transfected cells. These data suggest the existence of physical interaction between D3 and D3nf. This interaction appears to result in the mislocalization of D3 receptors from the plasma membrane to an intracellular compartment, a finding that could be of significance in the etiology of schizophrenia.
Similar articles
- The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerization.
Elmhurst JL, Xie Z, O'Dowd BF, George SR. Elmhurst JL, et al. Brain Res Mol Brain Res. 2000 Aug 14;80(1):63-74. doi: 10.1016/s0169-328x(00)00120-0. Brain Res Mol Brain Res. 2000. PMID: 11039730 - Functional rescue of the inactive splice variant of the dopamine D3 receptor D3nf.
Scarselli M, Novi F, Corsini GU, Maggio R. Scarselli M, et al. Brain Res. 2003 Oct 17;987(2):244-7. doi: 10.1016/s0006-8993(03)03360-2. Brain Res. 2003. PMID: 14499970 - Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia.
Schmauss C. Schmauss C. J Neurosci. 1996 Dec 15;16(24):7902-9. doi: 10.1523/JNEUROSCI.16-24-07902.1996. J Neurosci. 1996. PMID: 8987818 Free PMC article. - Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.
Richtand NM. Richtand NM. Neuropsychopharmacology. 2006 Nov;31(11):2368-75. doi: 10.1038/sj.npp.1301163. Epub 2006 Jul 19. Neuropsychopharmacology. 2006. PMID: 16855531 Free PMC article. Review. - Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
Carli M, Kolachalam S, Aringhieri S, Rossi M, Giovannini L, Maggio R, Scarselli M. Carli M, et al. Curr Neuropharmacol. 2018 Jan 30;16(2):222-230. doi: 10.2174/1570159X15666170518151127. Curr Neuropharmacol. 2018. PMID: 28521704 Free PMC article. Review.
Cited by
- Non-full-length Water-Soluble CXCR4QTY and CCR5QTY Chemokine Receptors: Implication for Overlooked Truncated but Functional Membrane Receptors.
Qing R, Tao F, Chatterjee P, Yang G, Han Q, Chung H, Ni J, Suter BP, Kubicek J, Maertens B, Schubert T, Blackburn C, Zhang S. Qing R, et al. iScience. 2020 Oct 28;23(12):101670. doi: 10.1016/j.isci.2020.101670. eCollection 2020 Dec 18. iScience. 2020. PMID: 33376963 Free PMC article. - Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty.
Pritchard LM, Logue AD, Taylor BC, Ahlbrand R, Welge JA, Tang Y, Sharp FR, Richtand NM. Pritchard LM, et al. Brain Res Bull. 2006 Oct 16;70(4-6):296-303. doi: 10.1016/j.brainresbull.2006.06.010. Epub 2006 Jul 13. Brain Res Bull. 2006. PMID: 17027765 Free PMC article. - Asymmetric conformational changes in a GPCR dimer controlled by G-proteins.
Damian M, Martin A, Mesnier D, Pin JP, Banères JL. Damian M, et al. EMBO J. 2006 Dec 13;25(24):5693-702. doi: 10.1038/sj.emboj.7601449. Epub 2006 Nov 30. EMBO J. 2006. PMID: 17139258 Free PMC article. - Dominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. Rescue of oligomerization-dependent defective receptor expression by using cognate decoys.
Zariñán T, Perez-Solís MA, Maya-Núñez G, Casas-González P, Conn PM, Dias JA, Ulloa-Aguirre A. Zariñán T, et al. Mol Cell Endocrinol. 2010 Jun 10;321(2):112-22. doi: 10.1016/j.mce.2010.02.027. Epub 2010 Mar 4. Mol Cell Endocrinol. 2010. PMID: 20206665 Free PMC article. - μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids.
Convertino M, Samoshkin A, Gauthier J, Gold MS, Maixner W, Dokholyan NV, Diatchenko L. Convertino M, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Oct 1;62:61-7. doi: 10.1016/j.pnpbp.2014.11.009. Epub 2014 Dec 6. Prog Neuropsychopharmacol Biol Psychiatry. 2015. PMID: 25485963 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous